Patents Assigned to Summit Innovation Labs LLC
  • Patent number: 11357250
    Abstract: The invention encompasses compositions and methods for effectively treating and/or preventing diabetes and/or obesity. This is accomplished by totally addressing the multiple mechanisms that lead to such conditions. The invention includes compositions comprising a combination of agents that effectively suppress, regulate or interfere with the various biochemical processes and mechanisms that lead to diabetes and obesity.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: June 14, 2022
    Assignee: Summit Innovation Labs LLC
    Inventors: Haile Mehansho, Satyanarayana Majeti, Ghebre Egziabher Tzeghai
  • Patent number: 11344575
    Abstract: The invention encompasses compositions and methods for effectively interfering, reducing and preventing conversion of vascular smooth muscle cells (VSMCs) and circulating stem cells to osteoblastic bone-like cells, thereby reducing and/or preventing vascular calcification (VC) or calcium mineral (hydroxyapatite) deposition in the vasculature. The severity and extent of calcification in the major arteries reflect atherosclerotic plaque burden and strongly predict cardiovascular morbidity and mortality.
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: May 31, 2022
    Assignee: Summit Innovation Labs, LLC
    Inventors: Satyanarayana Majeti, Haile Mehansho, Ghebre Egziabher Tzeghai
  • Patent number: 11039636
    Abstract: The invention encompasses compositions and methods for effectively treating and/or preventing the development and/or progression of osteoporosis and related disorders such as osteoarthritis and rheumatoid arthritis, and for promoting overall bone and joint health. This is accomplished by addressing multiple key mechanisms that lead to such disorders. The invention includes compositions comprising a combination of agents having biological activities that effectively suppress, regulate or interfere with the various key biochemical processes and mechanisms that increase the risk for development and/or progression of osteoporosis. The present compositions and methods simultaneously promote bone formation and reduce bone resorption by (a) stimulating osteoblast formation and osteogenesis; (b) suppressing adipocyte differentiation; (c) inhibiting osteoclast formation; and (d) increasing apoptosis of osteoclasts.
    Type: Grant
    Filed: May 13, 2019
    Date of Patent: June 22, 2021
    Assignee: Summit Innovation Labs, LLC
    Inventors: Ghebre Egziabher Tzeghai, Haile Mehansho, Satyanarayana Majeti
  • Patent number: 11007171
    Abstract: The invention encompasses compositions and methods for effectively treating and/or preventing the development and/or progression of osteoarthritis and rheumatoid arthritis and for promoting overall joint health. This is accomplished by totally addressing the key multiple biochemical processes and mechanisms that lead to such disorders. The invention includes compositions comprising a combination of natural agents that safely and effectively suppress, regulate or interfere with the various biochemical processes and mechanisms that increase the risk for or lead to the development and/or progression of OA and RA.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: May 18, 2021
    Assignee: Summit Innovation Labs, LLC
    Inventors: Haile Mehansho, Satyanarayana Majeti, Ghebre Egziabher Tzeghai
  • Publication number: 20190261668
    Abstract: The invention encompasses compositions and methods for effectively treating and/or preventing the development and/or progression of osteoporosis and related disorders such as osteoarthritis and rheumatoid arthritis, and for promoting overall bone and joint health. This is accomplished by addressing multiple key mechanisms that lead to such disorders. The invention includes compositions comprising a combination of agents having biological activities that effectively suppress, regulate or interfere with the various key biochemical processes and mechanisms that increase the risk for development and/or progression of osteoporosis. The present compositions and methods simultaneously promote bone formation and reduce bone resorption by (a) stimulating osteoblast formation and osteogenesis; (b) suppressing adipocyte differentiation; (c) inhibiting osteoclast formation; and (d) increasing apoptosis of osteoclasts.
    Type: Application
    Filed: May 13, 2019
    Publication date: August 29, 2019
    Applicant: Summit Innovation Labs LLC
    Inventors: Ghebre Egziabher Tzeghai, Haile Mehansho, Satyanarayana Majeti
  • Publication number: 20190015448
    Abstract: The invention encompasses compositions and methods for effectively treating and/or preventing osteoporosis and related disorders such as osteoarthritis and rheumatoid arthritis, and for promoting overall bone and joint health. This is accomplished by totally addressing the multiple mechanisms that lead to such disorders. The invention includes compositions comprising a combination of agents that effectively suppress, regulate or interfere with the various biochemical processes and mechanisms that increase the risk for development of osteoporosis. The present compositions and methods simultaneously promote bone formation and reduce bone resorption by (a) stimulating osteoblast formation and osteogenesis; (b) suppressing adipocyte differentiation; (c) inhibiting osteoclast formation; and (d) increasing apoptosis of osteoclasts.
    Type: Application
    Filed: February 28, 2018
    Publication date: January 17, 2019
    Applicant: Summit Innovation Labs LLC
    Inventors: Ghebre Egziabher Tzeghai, Satyanarayana Majeti, Haile Mehansho
  • Publication number: 20190015384
    Abstract: The invention encompasses compositions and methods for effectively treating and/or preventing the development and/or progression of osteoarthritis and rheumatoid arthritis and for promoting overall joint health. This is accomplished by totally addressing the key multiple biochemical processes and mechanisms that lead to such disorders. The invention includes compositions comprising a combination of natural agents that safely and effectively suppress, regulate or interfere with the various biochemical processes and mechanisms that increase the risk for or lead to the development and/or progression of OA and RA.
    Type: Application
    Filed: July 31, 2018
    Publication date: January 17, 2019
    Applicant: Summit Innovation Labs LLC
    Inventors: Haile Mehansho, Satyanarayana Majeti, Ghebre Egziabher Tzeghai
  • Publication number: 20180042962
    Abstract: The invention encompasses compositions and methods for effectively interfering, reducing and preventing conversion of vascular smooth muscle cells (VSMCs) and circulating stem cells to osteoblastic bone-like cells, thereby reducing and/or preventing vascular calcification (VC) or calcium mineral (hydroxyapatite) deposition in the vasculature. The severity and extent of calcification in the major arteries reflect atherosclerotic plaque burden and strongly predict cardiovascular morbidity and mortality.
    Type: Application
    Filed: July 13, 2017
    Publication date: February 15, 2018
    Applicant: Summit Innovation Labs LLC
    Inventors: Satyanarayana Majeti, Haile Mehansho, Ghebre Egziabher Tzeghai
  • Publication number: 20180042287
    Abstract: The invention encompasses compositions and methods for effectively treating and/or preventing diabetes and/or obesity. This is accomplished by totally addressing the multiple mechanisms that lead to such conditions. The invention includes compositions comprising a combination of agents that effectively suppress, regulate or interfere with the various biochemical processes and mechanisms that lead to diabetes and obesity.
    Type: Application
    Filed: August 11, 2017
    Publication date: February 15, 2018
    Applicant: Summit Innovation Labs LLC
    Inventor: Haile Mehansho